{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:06:06Z","timestamp":1789664766717,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jtct.2022.10.029","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T04:37:44Z","timestamp":1667536664000},"page":"41.e1-41.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3410-5121","authenticated-orcid":false,"given":"Simone","family":"Dertschnig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gergely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-5927","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-8392","authenticated-orcid":false,"given":"Urs","family":"Schanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Holtick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-7747","authenticated-orcid":false,"given":"Michael","family":"Medinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-2188","authenticated-orcid":false,"given":"Christos","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Oehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.10.029_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41571-020-0356-4","article-title":"Dissecting the biology of allogeneic HSCT to enhance the GVT effect whilst minimizing GVHD","volume":"17","author":"Blazar","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0002","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1182\/blood-2007-05-087940","article-title":"Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)","volume":"110","author":"Taylor","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.10.029_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153551","article-title":"Peri-transplant glucocorticoids redistribute donor T-cells to the bone marrow and prevent relapse after haploidentical SCT","volume":"6","author":"Inoue","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2022.10.029_bib0004","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions","volume":"398","author":"McGinley","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.10.029_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.106.119172","article-title":"A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice","volume":"324","author":"Song","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jtct.2022.10.029_bib0006","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","article-title":"FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory","volume":"164","author":"Pinschewer","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0007","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI200316950","article-title":"Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720","volume":"111","author":"Kim","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.10.029_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/eji.200636123","article-title":"FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease","volume":"37","author":"Hashimoto","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0009","first-page":"e613","article-title":"Sphingosine-1-phosphate receptor-1 agonist averts the de novo generation of autoreactive T-cells in murine acute graft-versus-host disease","volume":"5","author":"Vollmer","year":"2021"},{"key":"10.1016\/j.jtct.2022.10.029_bib0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41409-019-0733-8","article-title":"Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis","volume":"55","author":"Yokoyama","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2022.10.029_bib0011","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT\u2013ELN working group recommendations for a standardized practice","volume":"49","author":"Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.029_bib0012","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(14)60803-5","article-title":"Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"384","author":"Vaclavkova","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.10.029_bib0013","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbmt.2017.03.021","article-title":"Gastrointestinal toxicity, systemic inflammation, and liver biochemistry in allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Jordan","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.029_bib0014","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bmt.1702453","article-title":"Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study","volume":"26","author":"Kim","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.029_bib0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00004836-200305000-00013","article-title":"Causes and risk factors for liver injury following bone marrow transplantation","volume":"36","author":"\u00d6zdo\u011fan","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0016","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.029_bib0017","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1177\/1352458511435984","article-title":"A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis","volume":"18","author":"Saida","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jtct.2022.10.029_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-14-21","article-title":"Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension","volume":"14","author":"Kira","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0019","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1517\/14740338.2014.920820","article-title":"Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis","volume":"13","author":"Ward","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jtct.2022.10.029_bib0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0021","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.10.029_bib0022","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.10.029_bib0023","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbmt.2015.01.019","article-title":"Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome","volume":"21","author":"Kim","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.10.029_bib0024","doi-asserted-by":"crossref","first-page":"18819","DOI":"10.18632\/oncotarget.4710","article-title":"Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow","volume":"6","author":"Adamiak","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2022.10.029_bib0025","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3389\/fimmu.2018.02669","article-title":"Real world lab data: patterns of lymphocyte counts in fingolimod treated patients","volume":"9","author":"Kaufmann","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.10.029_bib0026","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722017419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:07:22Z","timestamp":1763003242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722017419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2666636722017419"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.10.029","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}